**Core Concept**
Non-alcoholic steatohepatitis (NASH) is a form of non-alcoholic fatty liver disease (NAFLD) characterized by inflammation and fibrosis in the liver, often resulting from an accumulation of fat in liver cells. This condition is closely linked to metabolic syndrome, which includes insulin resistance, obesity, and dyslipidemia.

**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of NASH, which involves an interplay between insulin resistance, adipose tissue dysfunction, and an abnormal lipid profile. Insulin resistance is a key factor in the development of NASH, leading to an increase in free fatty acids, which can cause liver injury and inflammation. **Option B: Obesity** is a major risk factor for NASH, as it is often associated with insulin resistance and metabolic syndrome.

**Why Each Wrong Option is Incorrect**
**Option A:** DM (Diabetes Mellitus) is a risk factor for NASH, but it is not the most direct or common association. While diabetes can contribute to insulin resistance and fatty liver disease, it is not the primary factor in NASH.
**Option C:** IHD (Ischemic Heart Disease) is not directly related to NASH, although both conditions can be associated with metabolic syndrome.
**Option D:** Gallstones are not a risk factor for NASH, although both conditions can be associated with obesity and metabolic syndrome.
**Option E:** Hypertriglyceridemia is a feature of metabolic syndrome and can contribute to the development of NASH, but it is not the most direct or common association.

**Clinical Pearl / High-Yield Fact**
NASH is often associated with other features of metabolic syndrome, including central obesity, hypertension, and dyslipidemia. A high index of suspicion for NASH should be maintained in patients with these risk factors, especially those with abnormal liver enzymes or imaging findings suggestive of fatty liver disease.

**Correct Answer:** B. Obesity